BMEA · Biomea Fusion, Inc. · Proposed Sales
$0.74
-0.10 (-11.96%)
At close · Oct 20
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 5, 2026
Substantial doubt about the company's ability to continue as a going concern.
“In connection with the preparation of this Quarterly Report on Form 10-Q for the period ended June 30, 2026, our management has concluded that there is substantial doubt as to whether we can continue as a going concern for the twelve months following the issuance of this Quarterly Report on Form 10-Q. Our ability to continue as a going concern is dependent upon raising capital to maintain current operations and continue research and development efforts. We plan to raise additional capital to fund our operations through public or private equity offerings, debt financings, and/or potential collaborations and license arrangement or other sources. There is no assurance, however, that any additional financing or any revenue-generating collaboration will be available when needed or that we will be able to obtain financing or enter into a collaboration on terms acceptable to us. Based on our current operating plan, we will not be able to continue as a going concern over the next twelve months unless we raise additional capital by other means. These factors raise substantial doubt about our ability to continue as a going concern.”View the 10-Q filed Aug 5, 2026
Market Cap
$54.07M
Shares
72.48M
Volume · Oct 20
3.55M
Avg daily vol (3M)
1.98M
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2023-05-19 | A2A Pharmaceuticals, Inc. | 10% Stockholder | 1,500,000 | 2023-05-19 | Jefferies LLC |
| 2023-04-27 | A2A Pharmaceuticals, Inc. | Stakeholder | 400,000 | 2023-04-27 | UBS Financial Services Inc |
| 2023-04-20 | A2A Pharmaceuticals, Inc. | 10% Stockholder | 200,000 | 2023-04-20 | Jefferies LLC |
Showing 1–3 of 3 filings